These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparison of Ranibizumab Treatment Response of Superior and Inferior Temporal Branch Retinal Vein Occlusion: A Year Follow-Up. Kumral ET; Yenerel NM; Ercalik NY; Karabas L Beyoglu Eye J; 2022; 7(3):207-212. PubMed ID: 36185983 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140 [TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Demir M; Oba E; Gulkilik G; Odabasi M; Ozdal E Clin Ophthalmol; 2011; 5():745-9. PubMed ID: 21750607 [TBL] [Abstract][Full Text] [Related]
28. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142 [TBL] [Abstract][Full Text] [Related]
30. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab. Spooner K; Fraser-Bell S; Hong T; Chang A Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950 [TBL] [Abstract][Full Text] [Related]
31. Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor. Eris E; Perente I; Erdogan G; Seymen Z; Sucu ME; Ozkaya A; Demircan A; Alkin Z; Demirok A; Artunay O Beyoglu Eye J; 2019; 4(1):11-16. PubMed ID: 35187425 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion. Çakmak HB; Arikan Yorgun M; Toklu Y; Mutlu M Turk J Med Sci; 2017 Feb; 47(1):40-46. PubMed ID: 28263518 [TBL] [Abstract][Full Text] [Related]
33. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion. Pichi F; Elbarky AM; Elhamaky TR Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022 [TBL] [Abstract][Full Text] [Related]
35. Afibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion. Irgat SG; Özcura F Arq Bras Oftalmol; 2023; 86(1):60-67. PubMed ID: 35417511 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Konstantinidis L; Mameletzi E; Mantel I; Pournaras JA; Zografos L; Ambresin A Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1165-71. PubMed ID: 19404661 [TBL] [Abstract][Full Text] [Related]
37. Time course of changes in contrast sensitivity following intravitreal ranibizumab injection for branch retinal vein occlusion. Sugiura Y; Okamoto F; Murakami T; Morikawa S; Hiraoka T; Oshika T Jpn J Ophthalmol; 2020 Sep; 64(5):497-505. PubMed ID: 32691257 [TBL] [Abstract][Full Text] [Related]
38. Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study. Minami Y; Nagaoka T; Ishibazawa A; Yoshida A BMC Ophthalmol; 2017 Jun; 17(1):90. PubMed ID: 28610573 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion. Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151 [TBL] [Abstract][Full Text] [Related]
40. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial. Song S; Yu X; Zhang P; Gu X; Dai H BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]